← The Wire
CYRXNasdaq
Cryoport, Inc.
Pharmaceutical Preparations · NV · CIK 1124524
Cryoport provides integrated, temperature-controlled supply chain solutions for life sciences, focusing on cell and gene therapies
$737M
Market cap
$16.28
Last close
+1.8%
1D
+10.2%
5D
965K
Volume
Price · last 39 sessions+59.5%
May 4L $10.21 · H $16.50Jun 29
358
Total filings
Jun 9, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 9, 20268-KResults of OperationsMay 4, 20268-KResults of OperationsMar 3, 20268-KResults of OperationsNov 4, 20258-KResults of OperationsAug 6, 20258-KAcquisition / Disposition · Reg FD DisclosureJun 13, 20258-KShareholder VoteJun 10, 20258-KResults of OperationsMay 7, 20258-KMaterial Agreement · Reg FD DisclosureMar 31, 20258-KResults of OperationsMar 4, 20258-KResults of OperationsNov 7, 20248-KResults of OperationsAug 6, 20248-KCompany UpdateAug 6, 20248-KShareholder VoteMay 22, 20248-KResults of OperationsMay 7, 20248-KResults of OperationsMar 12, 20248-KExecutive Change · Company UpdateFeb 15, 20248-KBylaw AmendmentNov 15, 20238-KResults of OperationsNov 8, 20238-KResults of OperationsAug 9, 20238-KResults of OperationsJul 12, 20238-KShareholder VoteMay 16, 20238-KResults of OperationsMay 4, 20238-KExecutive ChangeMar 28, 20238-KAuditor ChangeMar 15, 20238-KResults of OperationsFeb 23, 20238-KResults of OperationsNov 3, 20228-KResults of OperationsAug 4, 20228-KResults of OperationsMay 5, 20228-KShareholder VoteMay 5, 20228-KExecutive ChangeMar 21, 20228-KCompany UpdateMar 11, 20228-KResults of OperationsFeb 24, 20228-KCompany UpdateFeb 9, 20228-KCompany UpdateFeb 1, 20228-KMaterial Agreement · New Debt / ObligationNov 12, 20218-KCompany UpdateNov 10, 20218-KCompany UpdateNov 8, 20218-KResults of OperationsNov 4, 20218-KResults of OperationsAug 5, 20218-KExecutive Change · Shareholder VoteMay 5, 20218-KResults of OperationsMay 4, 20218-KExecutive ChangeMar 3, 20218-KResults of OperationsMar 1, 20218-KEquity Issuance · Reg FD DisclosureFeb 8, 20218-KCompany UpdateJan 25, 20218-KResults of Operations · Company UpdateJan 20, 20218-KCompany UpdateJan 19, 20218-KCode of EthicsJan 19, 20218-KResults of OperationsNov 5, 20208-KExecutive Change · Material AgreementOct 1, 20208-KMaterial Agreement · Equity IssuanceAug 25, 20208-KMaterial Agreement · Reg FD DisclosureAug 21, 20208-KResults of OperationsAug 7, 20208-KMaterial Agreement · New Debt / ObligationMay 27, 20208-KReg FD Disclosure · Company UpdateMay 21, 20208-KResults of OperationsMay 7, 20208-KShareholder VoteMay 5, 20208-KResults of OperationsMar 5, 20208-KResults of OperationsJan 9, 20208-KEquity IssuanceDec 19, 20198-KResults of OperationsNov 7, 20198-KExecutive ChangeOct 30, 20198-KCompany UpdateOct 9, 20198-KAuditor ChangeAug 20, 20198-KResults of OperationsAug 9, 20198-KMaterial AgreementJul 10, 20198-KCompany UpdateJun 24, 20198-KMaterial Agreement · Acquisition / DispositionMay 14, 20198-KResults of OperationsMay 3, 20198-KExecutive ChangeMay 3, 20198-KResults of OperationsMar 8, 20198-KExecutive ChangeJan 7, 20198-KMaterial Agreement · New Debt / ObligationDec 17, 20188-KMaterial AgreementAug 27, 20188-KShareholder VoteMay 18, 20188-KExecutive ChangeApr 3, 20188-KResults of OperationsMar 6, 20188-KCompany UpdateFeb 8, 20188-KReg FD DisclosureJan 2, 2018
Insider Activity
In the 90 days to Mar 23, 2026: 4 sold $471K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Shelton JerrellPresident, CEO | Sell | 2,894 | $8.18 | $24K |
| Mar 23, 2026 | Sawicki Mark WChief Scientific Officer | Sell | 1,341 | $8.18 | $11K |
| Mar 23, 2026 | Stefanovich RobertChief Financial Officer | Sell | 1,094 | $8.18 | $9K |
| Mar 16, 2026 | Shelton JerrellPresident, CEO | Sell | 7,918 | $8.00 | $63K |
| Mar 16, 2026 | Sawicki Mark WChief Scientific Officer | Sell | 3,235 | $8.00 | $26K |
| Mar 16, 2026 | Stefanovich RobertChief Financial Officer | Sell | 2,743 | $8.00 | $22K |
| Mar 16, 2026 | Zecchini Edward JSee Remarks | Sell | 2,014 | $8.00 | $16K |
| Mar 12, 2026 | Stefanovich RobertChief Financial Officer | Sell | 38,700 | $7.76 | $300K |
| Dec 10, 2025 | Mandalam RamkumarDirector | Sell | 11,570 | $9.99 | $116K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance